Keralty Hospital Miami | Keralty Research Center

Research site

Location

2500SW 75 Avenue, Miami, Florida, United States of America

Site insights

Top conditions

Top treatments

Palmitoylethanolamide

Niclosamide

Pomotrelvir

PEA

PBI-0451

APL-9

NP-120

Ifenprodil

Nitazoxanide

Baricitinib

Data sourced from clinicaltrials.gov

Contact this site

Maria T Bertoli

Verified by this site

Active trials

2 of 10 total trials

Bacteriophage Therapy TP-102 in Patients With Diabetic Foot Infection (REVERSE2)

TP-102 is a novel bacteriophage cocktail comprised of 5 (five) lytic bacteriophages against Staphylococcus aureus, Pseudomonas aeruginosa, and Acinet...

Enrolling

Diabetic Foot Infection

Biological: TP-102

Other: Placebo

PBI-0451 (Pomotrelvir) Phase 2 Study in Nonhospitalized Symptomatic Adults With COVID-19

This is a phase 2 double-blind, randomized study of PBI-0451(Pomotrelvir) in nonhospitalized symptomatic adults with COVID-19. PBI-0451(Pomotrelvir)...

Active, not recruiting

COVID-19

Drug: PBI-0451 (Pomotrelvir)

Drug: Placebo